Skip to content

RayStation

by RaySearch Laboratories AB (PUBL) 4 variants

510(k) K160093

RayStation is a medical device (FDA Class II; FDA product code MUJ, System, Planning, Radiation Therapy Treatment) made by RaySearch Laboratories AB (PUBL), cleared under FDA 510(k) K160093 on 8 Apr 2016, active as of 22 Oct 2026. 7 FDA recalls are linked to it.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

1 ongoing

This device is named in the recall

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK160093 Date8 Apr 2016ClearedStatusActive

Official records

From the FDA record

Received by the FDA
19 Jan 2016
FDA decision
8 Apr 2016 (Substantially Equivalent)
FDA review time
80 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K160093 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Recalls

7 recalls · 1 ongoing · FDA

    • Ongoing Z-1194-2025 FDA Class II initiated 16 Jan 2025

    Inconsistency in the use of Density uncertainty in the RayStation functions Robust optimization, Robust evaluation and Compute perturbed dose for proton and light ion treatment plans when a HU-to-mass density CT calibration curve used in RayStation version 4.5 to 2024B including some service packs.

    • Terminated Z-1815-2017 FDA Class II initiated 18 Jan 2017

    An error in NVIDIA GPU (Graphics Processing Unit) card drivers can occur for certain software programs. In a non-standard Citrix environment where the GPU settings are configured with a virtual Citrix graphics board (graphics card) an erroneous calculation may be allowed.

    • Terminated Z-0721-2017 FDA Class II initiated 9 Nov 2016

    Software anomaly; an issue was found with the proton Pencil Beam Scanning (PBS) dose calculation in RayStation 4.0, 4.5, 4.7 and 5.0. For treatment plans with a combination of range shifter, large air gap and beams that enter the patient surface at an oblique angle, the dose calculation accuracy may be less than expected.

    • Terminated Z-0720-2017 FDA Class II initiated 11 Oct 2016

    An error may occur with the display of dose computed on images other than the planning CT (auxiliary CT) when using multiple patient cases in RayStation 5. If a CT image set with the same Frame of Reference as the displayed auxiliary CT set exists in another case, the dose display may be incorrect. When the error occurs, the display of dose in patient views, including the maximum dose position, the dynamic isodose lines and the dose grid may be incorrect. The dose value normally displayed in the upper left corner when pointing in the 2D view may be incorrect or missing.

    • Terminated Z-0038-2017 FDA Class II initiated 1 Sep 2016

    RaySearch became aware of the problem as it was discovered in cooperation with a customer experimenting with the dose calculation on a phantom. The correction concerns two issues found with the dose calculation when using a region of interest (ROI) of type Fixation or Support with material override within the patient outline (External ROI) in RayStation 2.5, 3.0, 3.5, 4.0, 4.5, 4.7, 5.0 and 4.3 (InverseArc 1.0).

    • Terminated Z-2206-2016 FDA Class II initiated 1 Jul 2016

    An issue was found with the evaluation of biological clinical goals in RayStation 3.0, RayStation 3.5, RayStation 4.0, RayStation 4.5, RayStation 4.7 and RayStation 5. Biological clinical goals for an adapted plan based on another planning CT than the original planning CT will show incorrect values. -- To the best of the firm's knowledge, the issue has not caused any patient mistreatment or other incidents. However, the user must be aware of the following information to avoid incorrect plan evaluation during treatment planning.

    • Terminated Z-0079-2017 FDA Class II initiated 30 May 2016

    For a treatment plan consisting of multiple beam sets, the table for ROI plan dose statistics in the report may show the statistics for a beam set dose. The error can only be triggered when using a report template where statistics for a beam set dose is included as the last dose statistics prior to the plan dose statistics.

Timeline

8 dated events

  1. Cleared FDA 510(k) K160093
  2. Recall initiated FDA recalls Z-0079-2017
  3. Recall initiated FDA recalls Z-2206-2016
  4. Recall initiated FDA recalls Z-0038-2017
  5. Recall initiated FDA recalls Z-0720-2017
  6. Recall initiated FDA recalls Z-0721-2017
  7. Recall initiated FDA recalls Z-1815-2017
  8. Recall initiated FDA recalls Z-1194-2025

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
MUJ
Device class
Class II
Regulation
21 CFR Part 892.5050
Advisory committee
Radiology
FDA decision
SESE Substantially Equivalent

Devices cleared under K160093

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K160093
UDI-DISize and differences
RayStation 5.0.3
RaySearch Laboratories AB (PUBL)
5.0.307350002010020 —No longer on the market

Similar devices

Other devices filed under FDA product code MUJ (System, Planning, Radiation Therapy Treatment).

Other devices from RaySearch Laboratories AB (PUBL)

See all devices from RaySearch Laboratories AB (PUBL) →